Tag:
Chattem
Latest Headlines
Latest Headlines
Chattem's Allegra success buoys Sanofi diversification
For a data point on diversification, look no further than Sanofi's ( $SNY ) new Chattem unit. The French drugmaker snapped up U.S.-based Chattem to fortify its consumer healthcare business, and chief
OTC Allegra nod fortifies Sanofi's U.S. consumer ops
Sanofi-Aventis continues its diversification march. The company got the FDA's permission to sell its blockbuster allergy treatment Allegra without a prescription. Sanofi has been hoping for that OK
